期刊文献+

胰腺癌基因肿瘤标记物研究新进展 被引量:2

下载PDF
导出
摘要 胰腺癌为发病隐匿,进展迅速,预后极差的肿瘤。目前认为手术切除是胰腺癌唯一的可治愈性手段,然而,85%的胰腺癌患者就诊时已属晚期或发生远处转移,手术切除率仅10%~15%[1],故胰腺癌的早期诊断具有着非常重要的意义。
机构地区 大庆市龙南医院
出处 《中国伤残医学》 2011年第8期100-102,共3页 Chinese Journal of Trauma and Disability Medicine
  • 相关文献

参考文献14

  • 1Li D, Xie K, Wolff R,et al.Pancreatic cancer.Lancet, 2004,363: 1049-1057.
  • 2Ji B, Tsou L ,Wang H , et al. Ras activity Levels control the development of pancreatic diseases.Gastroenterology , 2009 , 137: 1072-1082.
  • 3Takahashi K,Yamao K,Okubo K, et al.Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest Endosc , 2005,61:76-79.
  • 4D? britz J, Preston R, H ?niler J, et al.Follow-up study of K-ras Mutations in the plasma of patients with pancreatic cancer. Pancreas, 2009,38:534-541.
  • 5Kim J,Reber HA,Dry SM , et al.Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins Gut, 2006,55:1598-1605.
  • 6Dong M, Nio Y, Yamasawa K, et al. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.Journal of Surgical Oncology, 2003,82:111-120.
  • 7Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR-155 s a biomarker of early pancreatic neoplasia.Cancer Biol Ther, 2009 , 8: 340-346.
  • 8Szafranska AE, Doleshal M, Edmunds HS. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem., 2005 , 54:1716-1724.
  • 9Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.JAMA, 2007,297:1901-1908.
  • 10Dillhoff M, Liu J, Frankel W, et al.MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg, 2008 , 12:2171-2171.

同被引文献29

  • 1胡先贵.努力提高胰腺癌术后长期生存率[J].第二军医大学学报,2005,26(8):842-844. 被引量:7
  • 2Shimada K, Sakamoto Y, Sano Y, et al. Reapprasial of the clinical significant of tumor size in patients with pancreatic ductal carcino- ma[ J]. Pancreas,2006,33 (3) :233-239..
  • 3Katz MH, Pisters PW, Evans DB, et al. Border/ine resectable pan- creatic cancer: the importance of this emerging stage of disease [ J ]. J Am Coil Surg,2008,206 (5) :833-846.
  • 4Ishikawa O, Ohigashi H, Yamada T, et al. Radical resection for pancreatic cancer [ J ]. Acta Gastroenterol Belg, 2002, 65 ( 3 ) : 166-170.
  • 5Yeo C J, Cameron JL, Lillemoe KD, et al. Pancreaticoduode-nectomy with or without distal gastrectomy and extended ret-roperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: ran- domized controlled trial evaluating survival, morbidity, and mortali- ty[ J]. Ann Surg,2002,236 ( 3 ) :355-368.
  • 6Beget HG, Gansauge F, Leder G. Pancreatic cancer: who benefits from curative resection [ J ]. Can J Gastroenterol, 2002, 16 ( 2 ) : 117-120.
  • 7Bilimoria KY, Bentrem D J, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U. S. :utilization,outcomes,and the effect of hospital volume [ J ]. Cancer, 2007,110 ( 6 ) : 1227-1234.
  • 8Di Carlo :, Gianotti L, Balzano G, et al. Complications of pancreat- ic surgery and the role of perioperative nutrition [ J ]. Dig Surg, 1999,16(4) :320-326.
  • 9Halloran CM, Ghaneh P, Bosonnet L, et al. Complications of pan- creatic cancer resection [ J ]. Dig Surg,2002,19 (2) ; 138-146.
  • 10Ellison NM, Chevlen E, Still CD, et al. Support care for patients with pancreatic adenocarcinoma: Symptom control and nutrition [ J ]. Hematol Oncol Clin North Am,2002,16 ( 1 ) : 105-121.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部